Abstract
Killer anti-idiotypes (KTantiId) bear the internal image of Pichia anomala toxin (KT), characterized by microbicidal activity against prokaryotic and eukaryotic pathogenic microorganisms presenting specific cell wall receptors (KTR). KTantiId produced by idiotypic vaccination with a KT-neutralizing monoclonal antibody confer active and passive immunoprotection in experimental models of systemic and vaginal candidiasis. KTantiId-like human natural anti-KTR antibodies are produced in natural infections caused by KT-sensitive microorganisms. KTantiId in the monoclonal and recombinant forms show therapeutic activity in experimental vaginal candidiasis and Pneumocystis carinii pneumonia. Human commensal bacteria expressing KTantiId or killer mimotopes synthesized from the sequence of KtantiId, may represent effective tools to combat fungal infections.
| Original language | English |
|---|---|
| Pages (from-to) | 477-479 |
| Number of pages | 3 |
| Journal | Current Opinion in Investigational Drugs |
| Volume | 2 |
| Issue number | 4 |
| Publication status | Published - 2001 |
Fingerprint
Keywords
- Anti-idiotypes
- Candidiasis
- Killer yeast
ASJC Scopus subject areas
- Pharmacology
Cite this
Killer anti-idiotypes in the control of fungal infections. / Magliani, W.; Conti, S.; Arseni, S.; Frazzi, R.; Salati, A.; Polonelli, L.
In: Current Opinion in Investigational Drugs, Vol. 2, No. 4, 2001, p. 477-479.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Killer anti-idiotypes in the control of fungal infections
AU - Magliani, W.
AU - Conti, S.
AU - Arseni, S.
AU - Frazzi, R.
AU - Salati, A.
AU - Polonelli, L.
PY - 2001
Y1 - 2001
N2 - Killer anti-idiotypes (KTantiId) bear the internal image of Pichia anomala toxin (KT), characterized by microbicidal activity against prokaryotic and eukaryotic pathogenic microorganisms presenting specific cell wall receptors (KTR). KTantiId produced by idiotypic vaccination with a KT-neutralizing monoclonal antibody confer active and passive immunoprotection in experimental models of systemic and vaginal candidiasis. KTantiId-like human natural anti-KTR antibodies are produced in natural infections caused by KT-sensitive microorganisms. KTantiId in the monoclonal and recombinant forms show therapeutic activity in experimental vaginal candidiasis and Pneumocystis carinii pneumonia. Human commensal bacteria expressing KTantiId or killer mimotopes synthesized from the sequence of KtantiId, may represent effective tools to combat fungal infections.
AB - Killer anti-idiotypes (KTantiId) bear the internal image of Pichia anomala toxin (KT), characterized by microbicidal activity against prokaryotic and eukaryotic pathogenic microorganisms presenting specific cell wall receptors (KTR). KTantiId produced by idiotypic vaccination with a KT-neutralizing monoclonal antibody confer active and passive immunoprotection in experimental models of systemic and vaginal candidiasis. KTantiId-like human natural anti-KTR antibodies are produced in natural infections caused by KT-sensitive microorganisms. KTantiId in the monoclonal and recombinant forms show therapeutic activity in experimental vaginal candidiasis and Pneumocystis carinii pneumonia. Human commensal bacteria expressing KTantiId or killer mimotopes synthesized from the sequence of KtantiId, may represent effective tools to combat fungal infections.
KW - Anti-idiotypes
KW - Candidiasis
KW - Killer yeast
UR - http://www.scopus.com/inward/record.url?scp=0035050103&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035050103&partnerID=8YFLogxK
M3 - Article
C2 - 11566002
AN - SCOPUS:0035050103
VL - 2
SP - 477
EP - 479
JO - Current Opinion in Investigational Drugs
JF - Current Opinion in Investigational Drugs
SN - 1472-4472
IS - 4
ER -